Polarimetry

Optical characterization

Therapeutic Modalities:

Small Molecules

Development Phases:

Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.2.7 or USP <781>